02 Sep InVitria
Jeff Zurwaski, Ph.D., Senior Manager Bioprocess Development, DiscGenics
Oct. 8 | 2:30pm | FLW Ballroom G
Boston, MA
(Private)
InVitria, Inc. was founded in 2008 to revolutionize biomanufacturing through the development, manufacturing, and marketing of recombinant proteins. Our mission is to empower scientists and biomanufacturers by providing sustainable, scalable, and high-performing technologies for cell & gene therapies, vaccines, biological products, IVF, and medical devices. We offer plant-based proteins and growth factors that eliminate the need for blood and serum components that are traditionally used in the manufacturing and formulation of therapeutics. The current supply of human and animal components cannot scale to support the future demand of therapeutics. Regulatory bodies like the FDA and EMA discourage the use of blood-derived proteins and serum due to potential risks and batch-to-batch variation, making InVitria’s technologies indispensable for industries seeking safer and more efficient biomanufacturing processes.
